Dolly’s Cancer Death; Mammogram Safety Alert; Chemo Drug Shortage Worsens
[post_content]
Disclaimer: This article has been automatically aggregated from
Representatives for entertainer Dolly Parton acknowledged that she died of cancer but did not identify the type of cancer; her sister, Stella, revealed that the singer and actress volunteered to take experimental drugs that might help other people. (People, Newsweek)
Parton’s admission that she ignored her own health problems while caring for her ailing husband highlighted a caregiver crisis in the U.S. (CNN)
A rare skin cancer that can be mistaken for eczema. (Washington Post)
The Justice Department announced that DermTech will pay $5 million to settle allegations that the company submitted false Medicare claims for unreliable skin cancer tests.
The FDA issued a safety alert, notifying patients of potential quality issues with mammograms performed at the Mammography Center of Monterey in California on or after Dec. 22, 2023.
An Iowa lawyer faces up to 10 years in prison and has agreed to pay $445,000 as restitution after admitting to defrauding Medicaid and patients with cancer by submitting false claims for breast prostheses. (Iowa Capital Dispatch)
Who’s to blame when artificial intelligence screws up coding and billing information? (Oncology News Central)
The American Society of Clinical Oncology added its voice to warnings about a critical shortage of the generic chemotherapy drug ifosfamide, following news that the FDA will temporarily allow imports of the drug from India.
Actress Busy Phillips revealed that her curiosity about whole-body MRI scans led to the discovery of an asymptomatic brain tumor. (USA Today)
A “tissue-free” approach to testing for circulating tumor DNA predicted breast cancer recurrence months before it showed up on imaging studies. (Institute for Cancer Research)
A study involving almost 15,000 patients with cancer supported what many people have said for years: Biosimilars save money for patients and payers. (UCLA Health)
A more granular approach to evaluating estrogen receptor (ER) expression — beyond classification as ER positive or negative — could affect treatment decisions for breast cancer. (Karolinska Institute)
Preclinical studies suggest a laboratory-developed oral drug might protect normal tissue from the adverse effects of radiation therapy. (Virginia Tech)
Music therapy showed promise as an intervention to reduce anxiety and depression in patients with cancer. (Drexel News)
An autopsy is pending for an Arkansas oncologist whose body was found in a lake 2 days after he was reported missing. (White River Now)
Laboratory studies produced evidence that fructose in food products may promote cancer metastasis. (Food and Wine)
for informational purposes only. We do not claim ownership, accuracy, or liability for the content provided. All rights belong to the original publisher.